VibekeStrandMD

PubMed

• Holistic approaches in systemic lupus erythematosus: do physicians avoid addressing difficult-to-treat but highly relevant symptoms?
  Ioannis Parodis, Chris Wincup, Zahi Touma, Jeanette Andersen, Vibeke Strand
  RMD Open. 2025-03-07
• Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X).
  Michael E Weinblatt, Peter C Taylor, Iain B McInnes, Tatsuya Atsumi, Vibeke Strand
  BMJ Open. 2025-03-05
• Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.
  Wils Nielsen, Fadi Kharouf, Carolina Munoz Grajales, Aarabi Thayaparan, Melanie Anderson
  Seminars in Arthritis and Rheumatism. 2025-02-27

Journal Articles

• Health-Related Quality of Life in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomised Controlled Trial  
  Micki Klearman, Vibeke Strand, John H Stone, BioMed Central
• Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus: 6 Years of Treatment  
  Vibeke Strand, MD, Arthritis Care & Research
• Blood Concentrations of Complement Split Product iC3b and Serum C3 Associate with SLE Disease Activity  
  Deepali P Sen, John P Atkinson, Vibeke Strand, Arthritis & Rheumatology
• Ixekizumab Improves Patient-Reported Outcomes up to 52 Weeks in bDMARD-Naïve Patients with Active Psoriatic Arthritis (SPIRIT-P1)  
  Alice B Gottlieb, Vibeke Strand, Rheumatology
• Patient-Reported Outcomes from a Randomized Phase III Trial of Sarilumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis  
  Vibeke Strand, MD, BioMed Central
• Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis over 2 Years: Results from the FUTURE 2 Study  
  Philip J Mease, Vibeke Strand, BioMed Central
• Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016  
  Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
• Response to M Boers concerns about Spydergrams  
  Strand V, Loftis J, Journal of Clinical Epidemiology, 1/1/2013
• Prevalence of Axial SpA in US Rheumatology Practices: Assessment of ASAS Criteria vs Rheumatology Expert Clinical Diagnosis  
  Strand V, Rao S, Shillington A, Cifaldi MA, McGuire M, Ruderman E, Arth Care & Research, 1/1/2013
• Improvements in Health Related Quality of Life with Belimumab, A B-lymphocyte Stimulator-specific Inhibitor, in Patients with Autoantibody-positive Systemic Lupus Eryt...  
  Strand V, Levy R, Cervera R, Petri MA, Birch H, Freimuth WW, Zhong J, Clarke AE for the BLISS-52 and -76 Study Groups, Annals Rheum Ds, 1/1/2013
• Efficacy and Safety of Epratuzumab in Patients with Moderate/Severe Active Systemic Lupus Erythematosus: Results from Emblem, A Phase Iib Randomized, Double Blind, Pla...  
  Wallace DJ, Kalunian K, Petri M, Strand V, Houssiau F, Pike M, Kilgallen B, Bongardt S, Barry A, Kelley L, Gordon C, Ann Rheum Ds, 1/1/2013
• Efficacy and Safety of Epratuzumab in Patients with Moderate/Severe Flaring Systemic Lupus Erythematosus: Results from Two Randomized, Double-blind, Placebo-controlled...  
  Wallace D, Gordon C, Strand V, Hobbs K, Petri M, Kalunian K, Houssiau F, Tak PP, Isenberg D, Kelley L, Kilgallen B, Barry AN, Wegener W, Goldenberg DM, Rheumatol, 1/1/2013
• From "inhibition of Radiographic Progression" to "maintaining Structural Integrity"  
  Landewe R, Strand V, van der Heijde D, Ann Rheum Ds, 1/1/2013
• Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study  
  Strand V, Schett G, Hu CC, Stevens R, J Rheumatol, 1/1/2013
• Predictors of Self Reported Health Related Quality of Life in Systemic Lupus Erythematosus (SLE)  
  Kiani AK, Strand V, Fang H, Jaranilla J, Petri M, Rheumatology, 1/1/2013
• Improvements in Patient-reported Outcomes with Apremilast, A Novel, Oral, Small Molecule, in the Treatment of Moderate to Severe Psoriasis: Results from a Phase IIb Ra...  
  Strand V, Fiorentino D, Hu C, Stevens R, Papp K, Health and QOL Review, 1/1/2013
• Reduced Joint Counts Misclassify Patients with Oligoarticular Psoriatic Arthritis and Miss Significant Numbers of Patients with Active Disease  
  Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, Helliwell PS on behalf of the GRACE Collaboration, Arth Rheum, 1/1/2013
• The Utility of Magnetic Resonance Imaging for Assessing Structural Damage in Randomized Controlled Trials in Rheumatoid Arthritis  
  Raganeth V, Strand V, Peterfy C, Ostergaard M, Deodhar A, Landewe R, Troum O, Conaghan P, Arth Rheum, 1/1/2013
• Long-term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-year Results from the RAPID 1 Trial an...  
  Keystone E, Landewe R, van Vollenhoven R, Combe B, Strand V et al, Ann Rheum Ds, 1/1/2013
• Epratuzumab for Patients with Moderate to Severe Flaring SLE: Health-related Quality of Life Benefits and Corticosteroid Use in the Randomized Controlled ALLEVIATE Tri...  
  Strand V, Petri M, Kalunian K, Gordon C, Wallace DJ, Hobbs K, Kelley L, Kilgallen B, Wegener WA, Goldenberg DM, Rheumatology, 1/1/2013
• Biosimilars: How similar?  
  Strand V, Cronstein B, Internal Medicine Journal, 1/1/2013
• Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core-Sets of Domains and Instruments for Use in Clinical Tr...  
  Sakatoo LA, Huscher D, Khanna D, Dellaripa PF, Distler O, Flarherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, ..., Thorax, 1/1/2013
• Comparison of Health-related Quality of Life in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis and Effects of Etanercept Treatment  
  Strand V, Sharp V, Koenig A, Park G, Shi Y, Wang B, Zack DJ, Fiorentino D, Ann Rheum Ds, 1/1/2012
• A Multicenter, Randomized Controlled Trial Comparing A Single Intra-articular Injection of Gel-200, A New Cross-linked Formulation of Hyaluronic Acid to Phosphate Buff...  
  Strand V, Baraf H, Lavin PT, Lim S, Hosokawa H, Osteoarth Cart, 1/1/2012
• A Phase II, Double-blind, Randomized, Placebo-controlled Study of BMS945429 (ALD518) in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate  
  Mease P, Strand V, Shalamberidze L, Dimic A, Raskina T, Xu L-A, Liu Y, Smith J and BMS945429 Study Group, Ann Rheum Ds, 1/1/2012
• Join now to see all

Other

• Functional Impairment Measurement in Psoriatic Arthritis: Importance and Challenges 
  Vibeke Strand, MD, Seminars in Arthritis & Rheumatism
  https://www.doximity.com/articles/09f8e5df-563f-4b90-b4e7-20086edbdd5c
  UpToDate, Wolters Kluwer Health - 2012-04-18